Acceptability and tolerability of longacting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV IMPAACT 2017MOCHA a second analysis of a phase 12 multicentre openlabel noncomparative dos

Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

ELSEVIER SCIENCE INC

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By